Welch & Forbes LLC Novartis Ag Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Novartis Ag stock. As of the latest transaction made, Welch & Forbes LLC holds 65,576 shares of NVS stock, worth $6.45 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

65,576

Previous 66,381 1.21%

Holding current value

$6.45 Million

Previous $7.07 Million 6.74%

% of portfolio

0.1%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$106.13 - $120.89 $85,434 - $97,316	-805 Reduced 1.21%	65,576 $7.54 Million
Q2 2024 Aug 01, 2024	SELL	$92.57 - $107.37 $251,142 - $291,294	-2,713 Reduced 3.93%	66,381 $7.07 Million
Q1 2024 May 02, 2024	SELL	$95.27 - $108.47 $90,506 - $103,046	-950 Reduced 1.36%	69,094 $6.68 Million
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $59,329 - $65,290	-643 Reduced 0.91%	70,044 $7.07 Million
Q3 2023 Nov 02, 2023	SELL	$94.73 - $105.13 $248,192 - $275,440	-2,620 Reduced 3.57%	70,687 $7.2 Million
Q2 2023 Jul 28, 2023	SELL	$92.52 - $104.91 $158,486 - $179,710	-1,713 Reduced 2.28%	73,307 $7.4 Million
Q1 2023 Apr 14, 2023	SELL	$80.03 - $92.81 $381,823 - $442,796	-4,771 Reduced 5.98%	75,020 $6.9 Million
Q4 2022 Feb 02, 2023	SELL	$75.55 - $92.52 $628,273 - $769,396	-8,316 Reduced 9.44%	79,791 $7.24 Million
Q3 2022 Oct 28, 2022	SELL	$74.61 - $87.26 $148,175 - $173,298	-1,986 Reduced 2.2%	88,107 $6.7 Million
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $53,223 - $61,968	-661 Reduced 0.73%	90,093 $7.62 Million
Q1 2022 Apr 25, 2022	SELL	$80.11 - $90.62 $58,400 - $66,061	-729 Reduced 0.8%	90,754 $7.96 Million
Q4 2021 Jan 19, 2022	BUY	$79.7 - $88.13 $174,303 - $192,740	2,187 Added 2.45%	91,483 $8 Million
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $130,030 - $151,272	-1,590 Reduced 1.75%	89,296 $7.3 Million
Q2 2021 Jul 22, 2021	BUY	$85.24 - $94.15 $2,898 - $3,201	34 Added 0.04%	90,886 $8.29 Million
Q1 2021 Apr 14, 2021	BUY	$83.5 - $98.47 $155,477 - $183,351	1,862 Added 2.09%	90,852 $7.77 Million
Q4 2020 Jan 20, 2021	BUY	$78.07 - $94.43 $300,257 - $363,177	3,846 Added 4.52%	88,990 $8.4 Million
Q3 2020 Oct 23, 2020	BUY	$82.14 - $91.0 $254,716 - $282,191	3,101 Added 3.78%	85,144 $7.4 Million
Q2 2020 Jul 15, 2020	SELL	$80.93 - $91.1 $20,556 - $23,139	-254 Reduced 0.31%	82,043 $7.17 Million
Q1 2020 Apr 17, 2020	SELL	$70.67 - $99.01 $17,667 - $24,752	-250 Reduced 0.3%	82,297 $6.79 Million
Q4 2019 Jan 17, 2020	SELL	$84.35 - $95.37 $95,315 - $107,768	-1,130 Reduced 1.35%	82,547 $7.82 Million
Q3 2019 Oct 11, 2019	BUY	$85.54 - $94.26 $84,171 - $92,751	984 Added 1.19%	83,677 $7.27 Million
Q2 2019 Jul 12, 2019	SELL	$75.4 - $92.8 $611,720 - $752,886	-8,113 Reduced 8.93%	82,693 $7.55 Million
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $167,888 - $192,028	-2,229 Reduced 2.4%	90,806 $8.73 Million
Q4 2018 Feb 05, 2019	SELL	$73.66 - $82.02 $3,462 - $3,854	-47 Reduced 0.05%	93,035 $7.98 Million
Q3 2018 Oct 17, 2018	SELL	$66.94 - $77.43 $1.14 Million - $1.32 Million	-17,049 Reduced 15.48%	93,082 $8.02 Million
Q2 2018 Jul 16, 2018	SELL	$64.91 - $73.36 $91,523 - $103,437	-1,410 Reduced 1.26%	110,131 $8.32 Million
Q1 2018 Apr 12, 2018	BUY	$70.39 - $84.15 $86,509 - $103,420	1,229 Added 1.11%	111,541 $9.02 Million
Q4 2017 Jan 26, 2018	BUY	$72.33 - $77.64 $63,071 - $67,702	872 Added 0.8%	110,312 $9.26 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $8.11 Million - $8.46 Million	109,440	109,440 $9.4 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account